{
  "url": "https://openlegislation.uk/medicines-and-medical-devices-act-2021/section-14",
  "json_url": "https://openlegislation.uk/medicines-and-medical-devices-act-2021/section-14.json",
  "legislation": "ukpga/2021/3",
  "legislation_title": "Medicines and Medical Devices Act 2021",
  "legislation_url": "https://openlegislation.uk/medicines-and-medical-devices-act-2021",
  "path": "section/14",
  "kind": "section",
  "number": "14",
  "heading": "Interpretation of Part 3 and supplementary provision",
  "text": "(1) In this Part—\n“active substance” means any substance or mixture of substances intended to be used in the manufacture of a veterinary medicine that, when used in its production, becomes an active ingredient of that medicine;\n“appropriate authority” has the meaning given by section 10(6);\n“manufacture” includes assembly;\n“marketing authorisation” means an authorisation to market a veterinary medicine in the United Kingdom;\n“veterinary medicine” means a veterinary medicinal product within the meaning given by regulation 2 of the Veterinary Medicines Regulations 2013 (S.I. 2013/2033).\n(2) In the Animals (Scientific Procedures) Act 1986, in section 2 (regulated procedures), in subsection (8)(d), after “the Veterinary Medicines Regulations 2011” insert “ or the Veterinary Medicines Regulations 2013 ”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukpga/2021/3/section/14",
    "retrieved_at": "2026-10-29T08:59:13.676472+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}